Nurix Therapeutics, Inc. NRIX Accrued And Other Liabilities Current
Accrued And Other Liabilities Current at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:AccruedAndOtherLiabilitiesCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accrued and other liabilities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accrued and other liabilities current?
- Nurix Therapeutics, Inc. (NRIX) reported accrued and other liabilities current of $59.95M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s accrued and other liabilities current changed year-over-year?
- Nurix Therapeutics, Inc.'s accrued and other liabilities current increased by 35.1% year-over-year, from $44.36M to $59.95M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accrued and other liabilities current?
- Over 2 years (2020 to 2025), Nurix Therapeutics, Inc.'s accrued and other liabilities current has grown at a 156.6% compound annual growth rate (CAGR), from $8.33M to $54.85M.
- What does accrued and other liabilities current mean?
- This category encompasses miscellaneous short-term obligations that do not fall under specific line items such as payroll, taxes, or trade payables. It provides a catch-all view of the company's current operational liabilities that must be settled within the next fiscal year.